Lee Clare J, Clark Jeanne M, Asamoah Vivian, Schweitzer Michael, Magnuson Thomas, Lazo Mariana
Division of Endocrinology, Diabetes and Metabolism, The Johns Hopkins University, Baltimore, Maryland.
Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins University, Baltimore, Maryland; Department of Medicine, Division of General Internal Medicine, The Johns Hopkins University, Baltimore, Maryland.
Surg Obes Relat Dis. 2015 Jan-Feb;11(1):142-6. doi: 10.1016/j.soard.2014.06.012. Epub 2014 Jun 19.
Recent studies describe a unique subset of obese individuals with normal metabolic profiles despite having excess weight called "metabolically healthy but obese (MHO)". Our aim was to determine the prevalence of individuals without diabetes and hypertension and risk factors associated with the MHO phenotype among bariatric surgery patients.
We conducted a retrospective study of 710 adults who underwent bariatric surgery at Johns Hopkins between 2008 and 2010. In the first analysis of 523 individuals, we identified 150 individuals without diabetes and hypertension; in the second analysis of 260 individuals, we identified 44 individuals without diabetes, hypertension and hypertriglyceridemia. We used multivariable logistic regression to examine the association between each group and potential risk factors including age, sex, race, body mass index, and presence of liver disease on liver biopsy.
The prevalence of individuals without diabetes and hypertension was 28.7%; among these individuals 88.7% had liver steatosis, 7.3% nonalcoholic steatohepatitis (NASH), and 19.3% liver fibrosis. These individuals were significantly more likely to be white OR=1.9 (95% CI: 1.1-3.1), younger OR=4.1 (95% CI=2.6-6.3), and female OR=2.1, (95% CI=1.2-3.6) and less likely to have liver steatosis OR=0.4 (95% CI=0.2-0.9) or NASH OR=0.3 (95% CI=0.2-0.6).
Among bariatric surgery patients, almost a third of patients do not have diabetes and hypertension and could be probably considered "MHO" and were more likely to be white, young, female, and have less liver injury. The high prevalence of liver steatosis in MHO individuals among bariatric surgery patients challenges the notion of MHO as a truly metabolically healthy entity.
最近的研究描述了一类独特的肥胖个体,尽管体重超标,但代谢状况正常,被称为“代谢健康的肥胖者(MHO)”。我们的目的是确定在接受减肥手术的患者中,无糖尿病和高血压的个体的患病率以及与MHO表型相关的危险因素。
我们对2008年至2010年间在约翰霍普金斯医院接受减肥手术的710名成年人进行了一项回顾性研究。在对523名个体的首次分析中,我们确定了150名无糖尿病和高血压的个体;在对260名个体的第二次分析中,我们确定了44名无糖尿病、高血压和高甘油三酯血症的个体。我们使用多变量逻辑回归来检验每组与潜在危险因素之间的关联,这些危险因素包括年龄、性别、种族、体重指数以及肝活检时是否存在肝病。
无糖尿病和高血压的个体的患病率为28.7%;在这些个体中,88.7%有肝脂肪变性,7.3%有非酒精性脂肪性肝炎(NASH),19.3%有肝纤维化。这些个体更有可能是白人(OR=1.9,95%CI:1.1 - 3.1)、更年轻(OR=4.1,9%CI=2.6 - 6.3)以及女性(OR=2.1,95%CI=1.2 - 3.6),并且患肝脂肪变性(OR=0.4,95%CI=0.2 - 0.9)或NASH(OR=0.3,95%CI=0.2 - 0.6)的可能性更小。
在接受减肥手术的患者中,近三分之一的患者没有糖尿病和高血压,可能被视为“MHO”,并且更有可能是白人、年轻人、女性,且肝损伤较轻。减肥手术患者中MHO个体肝脂肪变性的高患病率对MHO作为真正代谢健康实体的观念提出了挑战。